Slater Technology Fund invests $500K in MindImmune Therapeutics

MindImmune Therapeutics is a South Kingstown-based pharmaceutical startup./ LOGO COURTESY MINDIMMUNE
MindImmune Therapeutics is a South Kingstown-based pharmaceutical startup.
PROVIDENCE – MindImmune Therapeutics Inc. will receive $500,000 in seed funding from Slater Technology Fund to support the drug discovery venture’s launch. MindImmune Therapeutics is treating central nervous system diseases such as Alzheimer’s and Huntington’s disease, as well as pain and psychiatric disorders, by developing drugs targeting the immune system. “Research advances over the past…
Free Access WeekRegister to read all articles free until July 29! One week only, get full access to all articles on PBN.com when you create a complimentary account. Register Now Already a Subscriber or Registrant? Login now

No posts to display